Delivery Order SPE2DB24D1021-SPE2DB25FEYYY
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $16,372.29 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, awarded on August 4, 2025, represents a non-competitive set-aside contract and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,388.63 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a non-competitive, non-set-aside award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,723.83 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The delivery will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,034.58 on May 12, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,352.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 25, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a $30,806.33 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, with a completion date of June 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location, leveraging its established role as a critical pharmaceutical distributor for federal military...
- The Defense Logistics Agency awarded a delivery order valued at $12,030.67 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets (quantity: 30 units). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order represents a child...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYYYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,354.64 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill complex pharmaceutical procurement requirements, spanning brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for DESCOVY, an antiretroviral medication, reflects AmerisourceBergen's ongoing role in supporting military and veteran healthcare supply chains through the DLA's medical procurement network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.4k | 7/24/25 |